Mosanna Therapeutics
PrivateLast Round
Series A
Jun 9, 2025
Total Funding Raised
$80M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mosanna Therapeutics is a biotechnology company that develops pharmaceutical therapeutics designed to treat obstructive sleep apnea through non-mechanical approaches.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mosanna Therapeutics Comparables
Compare Mosanna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apnimed | 89% | |
| Incannex Healthcare Inc. | 76% | |
| Shionogi & Co. | 68% | |
Mosanna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 9, 2025 | ||||
| Seed | Jul 13, 2022 |
Mosanna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A |
| Forbion | Series A |
| Forty51 Ventures | Series A, Seed |
| Norwest Venture Partners | Series A |
| Pivotal bioVenture Partners | Series A |
| Pivotal bioVenture Partners | Series A |
| Supermoon Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 140% MoM, reaching 2.1K.
- Jun 20, 2025
David Weber appointed President and CEO.
Mosanna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mosanna Therapeutics's valuation, stock price, and market status.